Intralesional Steroid Injection Therapy of the Benign Vocal Fold Lesions

Voice therapy and laryngeal microsurgery are the main treatment options for benign vocal fold lesions. However, if patients are unable to endure lengthy voice therapy, or refuse surgery under general anesthesia, clinicians need to try other methods. Recently local steroid injection directly into the true vocal folds (TVF) benign lesions has been focused on alternative treatment options, and good results have been reported. Local steroid injection into the TVF was first described in 1964 by Dr. Yanagihara. Although this initial technique was inaccurate, however, with the advancement of modern endoscopy, recent emerging articles have proposed for the effectiveness of in-office awake vocal fold steroid injection in the treatment of benign vocal fold lesions. Based on previous studies of vocal fold steroid injection in the treatment of benign vocal fold lesions, I will summarize and suggest as follows. Various corticosteroids (triamcinolone acetonide, methylprednisolone, dexamethasone sodium phosphate) are used for the intralesional injection in the treatment of benign vocal fold lesions. The steroid injection approach can be transoral, transcutaneous or via flexible endoscope with operating channel, and injection route depends mainly on availability and individual experience. Intralesional corticosteroid injection significantly reduces benign vocal fold lesion volume and improves voice quality, at least transiently. There are many unresolved issues remain regarding the problem of vocal fold atrophy after steroid injection. Nevertheless, to minimize the risk of vocal atrophy, it is advisable to pay attention to repeating short interval steroid injection or administrating high dose of steroid. And, in case where repeated steroid injections are necessary for benign vocal fold lesions such as vocal nodule, vocal polyp, Reinke’s edema, I suggest that 12 weeks intervals would be safe to prevent vocal fold atrophy. And, to prevent recurrence of benign vocal fold lesions after steroid injection therapy, it is recommended to add post-procedural voice therapy, including vocal hygiene.

Authors

Publication Details

Journal
Journal of The Korean Society of Laryngology Phoniatrics and Logopedics
Published
2024-12-30
DOI
https://doi.org/10.22469/jkslp.2024.35.3.85
Primary Topic
Voice and Speech Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Intralesional Steroid Injection Therapy of the Benign Vocal Fold Lesions

Sung Min Jin
Journal of The Korean Society of Laryngology Phoniatrics and Logopedics
Voice and Speech Disorders
article

Intralesional Steroid Injection Therapy of the Benign Vocal Fold Lesions

Sung Min Jin
article en

Abstract

Voice therapy and laryngeal microsurgery are the main treatment options for benign vocal fold lesions. However, if patients are unable to endure lengthy voice therapy, or refuse surgery under general anesthesia, clinicians need to try other methods. Recently local steroid injection directly into the true vocal folds (TVF) benign lesions has been focused on alternative treatment options, and good results have been reported. Local steroid injection into the TVF was first described in 1964 by Dr. Yanagihara. Although this initial technique was inaccurate, however, with the advancement of modern endoscopy, recent emerging articles have proposed for the effectiveness of in-office awake vocal fold steroid injection in the treatment of benign vocal fold lesions. Based on previous studies of vocal fold steroid injection in the treatment of benign vocal fold lesions, I will summarize and suggest as follows. Various corticosteroids (triamcinolone acetonide, methylprednisolone, dexamethasone sodium phosphate) are used for the intralesional injection in the treatment of benign vocal fold lesions. The steroid injection approach can be transoral, transcutaneous or via flexible endoscope with operating channel, and injection route depends mainly on availability and individual experience. Intralesional corticosteroid injection significantly reduces benign vocal fold lesion volume and improves voice quality, at least transiently. There are many unresolved issues remain regarding the problem of vocal fold atrophy after steroid injection. Nevertheless, to minimize the risk of vocal atrophy, it is advisable to pay attention to repeating short interval steroid injection or administrating high dose of steroid. And, in case where repeated steroid injections are necessary for benign vocal fold lesions such as vocal nodule, vocal polyp, Reinke’s edema, I suggest that 12 weeks intervals would be safe to prevent vocal fold atrophy. And, to prevent recurrence of benign vocal fold lesions after steroid injection therapy, it is recommended to add post-procedural voice therapy, including vocal hygiene.

Journal of The Korean Society of Laryngology Phoniatrics and LogopedicsVol. 35(3)
Good health and well-being
Openalex Percentile: Top 66%
Voice and Speech Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.